Bob Valamehr, PhD MBA,
Dr Bijal Shah
Matthew Hewitt
Jason Fierings
Blythe Sather
Robert Tighe
Neil Sheppard
Joern-Peter Halle
Peter is leading the Translational Innovation Platform Immuno-Oncology with global responsibility for the research, discovery, and translational aspects of Merck KGaA’s IO portfolio. As the global head for External Innovation he oversees the search & evaluation of external opportunities in all therapeutic areas ranging from academic collaborations to clinical assets. He is also responsible for innovation initiatives of the healthcare business and a member of the investment committee of Merck Venture, Merck KGaA’s corporate VC. He started his carrier in Merck KGaA 12 years ago as a member of the corporate development. Prior to joining Merck KGaA, he co-founded a biotech company focusing on R&D in dermatology where he was responsible for IP, bioinformatics, and technology development and served as a Chief Business Officer.
